Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.960166625
Author: Trendlyne DVM scores

Mid-range Performer

about

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

1488.70 30.60 (2.10%)

67.46% Gain from 52W Low

214.5K

NSE+BSE Volume

NSE 13 Feb, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

57.5 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

1,795

1Yr Price target upside is 21%

6 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

67.46% Gain from 52W Low

SWOT Analysis

Emcure Pharma Live Price Chart